Kimberly A. Foster
Keine laufenden Positionen mehr
Profil
Kimberly Foster is Vice President of Research and Development for CS-Keys, Inc. Prior to joining CS-Keys, she was an Associate Director of Analytical Development for BioVest International, Inc. Dr. Foster held various senior positions at GSK Biologicals, Microbiotix, Inc., and Bayer Diagnostics Corp.
She received a PhD in Biochemistry from the Medical College of Virginia.
Ehemalige bekannte Positionen von Kimberly A. Foster
| Unternehmen | Position | Ende |
|---|---|---|
Microbiotix, Inc.
 Microbiotix, Inc. Pharmaceuticals: MajorHealth Technology Microbiotix, Inc. is a clinical stage biopharmaceutical company located in Worcester, MA. The private company's lead therapeutic compound, mbx-400, is a potent and novel nucleoside analog dual DNA polymerase/kinase inhibitor for the treatment of human cytomegalovirus (CMV). Microbiotix has consistently been the top recipient of NIH awards amongst biotech/pharma companies, which is a testament to their innovation. The company was founded by Wendy E. Rieder and is focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases, including multi-drug resistant pathogens. | Corporate Officer/Principal | - |
| Bayer Diagnostics Corp. | Corporate Officer/Principal | - |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
| Bayer Diagnostics Corp. | Health Technology |
Microbiotix, Inc.
Microbiotix, Inc. Pharmaceuticals: MajorHealth Technology Microbiotix, Inc. is a clinical stage biopharmaceutical company located in Worcester, MA. The private company's lead therapeutic compound, mbx-400, is a potent and novel nucleoside analog dual DNA polymerase/kinase inhibitor for the treatment of human cytomegalovirus (CMV). Microbiotix has consistently been the top recipient of NIH awards amongst biotech/pharma companies, which is a testament to their innovation. The company was founded by Wendy E. Rieder and is focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases, including multi-drug resistant pathogens. | Health Technology |
